ClinicalTrials.gg
Not yet recruitingNCT06570590Updated Aug 26, 2024

Prospective Study of Minimally Invasive Lapidus Procedure for Hallux Valgus Deformities

An interventional study of Minimally invasive lapidus procedure with no arthroscopy and Minimally invasive lapidus procedure with arthroscopy in Hallux Valgus and Bunion, sponsored by St. Paul's Hospital, Canada. Not yet recruiting at 1 site in Canada. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2024-08-26.

Sponsored by St. Paul's Hospital, Canada · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
58
Allocation
Randomized
Ages
19 Years and older
Sex
All
01

Study summary

The Lapidus procedure corrects bunions, a condition called hallux first ray deformity. Using minimally invasive surgery (MIS) to perform this procedure on patients with hallux valgus deformity is a newer approach. Because it's newer, there is not studies on how patients feel about it directly through patient reported outcomes (PROMs), which involve patients filling out questionnaires. Previous studies have looked at information that could be gathered from radiographs. This study looks specifically at how well bones heal after the MIS procedure and how patients feel about it based on their recorded responses in PROMs. The Lapidus procedure involves a step where the surgeon checks for the amount of cartilage removal, which can be done by inserting a mini camera into the joint (arthroscopically) or through a small incision for visual inspection. These two methods of checking cartilage removal are the two treatment groups for this study that patients are randomly assigned to.

The main goals of the study are as follows:

  • To determine healing in minimally invasive Lapidus. Evaluated by bones fusing together at 12 weeks post-operation.
  • To determine patient reported outcomes following Lapidus procedures
  • To determine the relationship between patient-reported outcomes and percent bone healing.
  • To assess the nonunion (bone not fusing together) rate and re-operation rate following Lapidus procedures
  • To assess the correction achieved on radiographic and standing CT measurements.
  • To compare radiographic and Standing CT assessment of hallux valgus deformity and correction after surgery.
02

Conditions studied

  • Hallux Valgus and Bunion
03

In context

Hallux Valgus

157 studies on the registry are indexed under Hallux Valgus; 36 are open to participants now.

This study's planned enrollment of 58 is close to the median of 58 across 119 interventional studies indexed under Hallux Valgus.

Browse Hallux Valgus studies →

Lead sponsor

St. Paul's Hospital, Canada is the lead sponsor of 32 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • The subject is at least 19 years of age.
  • The subject is considered to be skeletally mature.
  • The subject is undergoing an isolated 1st TMT, which may or may not include concomitant procedures, such as:

    • Soft tissue realignment
    • Heel cord lengthening
    • Akin osteotomy
    • Lesser toe osteotomies or claw toe correction
  • The subject is able to comply with all post-operative evaluations and visits.
  • The subject is able to provide .
  • The subject consents to and will receive either arthroscopy or no arthroscopy condition using the PROstep MIS 5mm Chamfer Screw.

Exclusion criteria

Exclusion Criteria:

  • Patients indicated for TMT fusion for non-hallux valgus procedures.
  • Patients with simultaneous fusion of second and third ray.
  • Patients indicated for navicular-cuneiform joint performed at the same time.
  • The subject has:

    • Arthritis in the affected joint
    • Severe osteoporosis
    • Neuromuscular impairment
    • Prior or current infection in the affected joint
    • Charcot foot
  • The subject has undergone previous fusion surgery of the proposed site (i.e., revision of failed fusion attempt).
  • The subject will be undergoing an ankle replacement, any other concomitant fusion(s), or any lesser metatarsal osteotomies in the affected foot or ankle in the same sitting.
  • The subject has concomitant injury, which in the opinion of the Investigator, is likely to impair functions for as long as or longer than the recovery from the subject's 1st TMT fusion.
  • The subject is deemed morbidly obese ( \> 50 kg/m2
  • The subject has a major risk factor for non-union (ex. poorly controlled diabetes, current smoker).
  • There is radiographic evidence of bone cysts, segmental defects or growth plate fracture around the fusion site that may negatively impact bony fusion. The patient currently has untreated malignant neoplasm(s), or is currently undergoing radio- or chemotherapy or has been diagnosed with hypercalcemia.
  • The subject is known to be pregnant during the study period.
  • The Investigator judges the subject to be unable or unlikely to remain compliant to follow-up due to a physical or mental condition (ex. currently being treated for a psychiatric disorder, senile dementia, Alzheimer's disease, etc.).
  • The subject is unable to provide .
  • The subject is unable to communicate with the research team.
  • The subject is unable to comply with follow-up.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
58 participants (estimated)

Study arms

  • Active comparator
    Arthroscopy

    Using arthroscopy in minimally invasive lapidus procedure is the current standard of care. However a new screw is used (PROstep MIS 5mm Chamfer Screw). The new hardware is expected to be substantially equivalent to standard of care.

    Procedure: Minimally invasive lapidus procedure with arthroscopy

  • Experimental
    No Arthroscopy

    Non-Arthroscopic Mini Arthrotomy Procedure (research-specific): Surgical procedure between the two treatment groups are equivalent except at the step of checking cartilage removal. After use of the cartilage burr the surgeon will make a small dorsal portal and use this to ensure that the cartilage is removed and all debris removed. The incision will be 2 cm long and centered over the dorsal medial aspect of the joint. The Principal Investigator wants to know if the mini arthrotomy procedure is as effective as the control because this procedure is faster and easier to perform.

    Procedure: Minimally invasive lapidus procedure with no arthroscopy

Interventions

  • ProcedureMinimally invasive lapidus procedure with no arthroscopy

    The two procedures, with and without arthroscopy, only differ by the method of assessing cartilage removal. Cartilage removal will be assessed arthroscopically in the procedure with arthroscopy. In the procedure without arthroscopy, cartilage removal will be assessed via direct visualization through a mini arthrotomy procedure. After use of the cartilage burr the surgeon will make a small dorsal portal and use this opening to ensure that the cartilage is removed and all debris removed. The incision will be 2 cm long and centered over the dorsal medial aspect of the joint.

    Also known as: No arthroscopy, MIS no arthroscopy, mini arthrotomy

  • ProcedureMinimally invasive lapidus procedure with arthroscopy

    After removal of the cartilage with the cartilage burr, a 3.0 arthroscope will be inserted to inspect the joint for all cartilage removal. Any residual cartilage pieces will be removed to ensure complete cartilage debridement from the subchondral bone and fragments removed from the joint.

    Also known as: With scope

06

What researchers measure

Primary outcomes

  1. Primary: Bone Fusion

    Rate of bone fusion by comparing the mean percentage of the joint fused at Week 12 using LineUp scans

    Time frame: At 12 weeks post-operation

Secondary outcomes

  1. Secondary: Questionnaires-Musculoskeletal Outcomes Data Evaluation and Management System (MODEMS)

    Patient reported outcomes as measured by MODEMS (includes AOS and SF-36) compared to baseline questionnaire.

    Time frame: Pre-operative, and at all post-operative followups (2 Weeks, 6 Weeks, 12 Weeks, 52 Weeks)

  2. Secondary: Questionnaires-Foot and Ankle Ability Measure (FAAM)

    Patient reported outcomes as measured by FAAM compared to baseline questionnaire.

    Time frame: Pre-operative, and at all post-operative followups (2 Weeks, 6 Weeks, 12 Weeks, 52 Weeks)

  3. Secondary: Questionnaires-Pain Catastrophizing Scale (PCS)

    Patient reported outcomes as measured by PCS compared to baseline questionnaire.

    Time frame: Pre-operative, and at all post-operative followups (2 Weeks, 6 Weeks, 12 Weeks, 52 Weeks)

  4. Secondary: Re-operation and complication rates

    Reoperations and complications will be recorded

    Time frame: At any point during enrolment up to 52 weeks post-operation.

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2024; primary completion for Oct 2026, 24 months later.

Of 51 non-industry interventional studies with no phase under Hallux Valgus, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 55. This study's planned 24 months is close to that.

Counting every sponsor, half of 56 studies reached it within 26 months; a quarter within 11 and three quarters within 55.

How these figures are worked out, and which studies are left out of them.

Registered
May 14, 2024
First posted
Aug 26, 2024
StartEst.
Oct 1, 2024
Primary completionEst.
Oct 1, 2026
CompletionEst.
May 1, 2027
Last update
Aug 26, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 26, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06570590
Lead sponsor
St. Paul's Hospital, Canada
Collaborators
Stryker Nordic
Responsible party
Alastair Younger (Orthopaedic Surgeon, University of British Columbia) — Principal investigator
First posted
Aug 26, 2024
Start date
Oct 1, 2024 (estimated)
Primary completion
Oct 1, 2026 (estimated)
Completion
May 1, 2027 (estimated)
Last update
Aug 26, 2024

Study contacts

Biraj Bora
Contact
bbora@providencehealth.bc.ca
604-813-0889
Alastair Younger
Contact
asyounger@shaw.ca
604-317-0489
Alastair Younger
principal investigator · University of British Columbia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion